3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Rett Syndrome: new trials by email Literature Review of Rett Syndrome trials Research Report on Rett Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) NTI164 - Rett Syndrome | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 14 | 2023-09-20 | 2026-09-09 |
| Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome fingolimod (FTY720) - Rett's Syndrome | Phase 1 / Phase 2 | Completed | University Hospital, Basel, Switzerland | 6 | 2013-08-01 | 2018-06-15 |
| Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection) rhIGF-1 - Rett Syndrome | Phase 1 | Completed | Boston Children's Hospital | 12 | 2010-12-01 | 2017-06-22 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Heredodegenerative Disorders, Nervous System (3) · Intellectual Disability (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · X-Linked Intellectual Disability (3)
Fingolimod Hydrochloride (1) · mecasermin (1)
Boston Children's Hospital (1) · Fenix Innovation Group (1) · University Hospital, Basel, Switzerland (1)
Australia (1) · Switzerland (1) · United States (1)
Ludwig Kappos, Prof. (1) · Mustafa Sahin, MD, PhD (1)